Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

<< Previous
Bullboard Posts
Next >>
Post by StoneMan45on Sep 03, 2021 3:51pm
190 Views
Post# 33810573

viv

vivbought 25,000 but I guess some don't show. 

new patent application published for mastistis  https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20210826&CC=WO&NR=2021163786A1&KC=A1
The present invention features animal feed comprising an effective amount of carotenoid-oxygen copolymer for use in methods for: (i) ameliorating one or more symptoms of subclinical mastitis; (ii) reducing the frequency of subclinical mastitis progressing to full clinical mastitis; (iii) reducing bacteria count in colostrum or milk of a mammal; (iv) reducing physiological stress of a mammal; (v) improving reproductive performance of a mammal; and/or (vi) improving the health of offspring of a mammal. The invention also features a method for producing pasteurized milk from a mammal which has been fed the animal feed supplemented with carotenoid-oxygen copolymer.



and new pesentation on their site https://www.avivagen.com/wp-content/uploads/AVIVAGEN-CMS-BANFF-CONFERENCE-PRESENTATION.pdf
<< Previous
Bullboard Posts
Next >>